Skip to main content
CXAI
NASDAQ Technology

Shareholders Approve Highly Dilutive Equity Program & Reverse Stock Split Authorization

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
9
Price
$0.222
Mkt Cap
$15.497M
52W Low
$0.131
52W High
$1.15
52W Position info
70% above low
Off High info
81% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

CXAI sits 70% above its 52-week low of $0.131 on light trading volume (0.2× avg).

Summary

CXApp Inc. shareholders approved a highly dilutive equity issuance program and authorized a reverse stock split to maintain its Nasdaq listing, following previous disclosures of financial distress and delisting threats.


Key Events · Financing and Capital Events · CXAI

  • Dilutive Equity Issuance Approved

    Shareholders approved the issuance of common stock (or convertible securities) in private placements exceeding 20% of outstanding shares, enabling the previously disclosed $40 million highly dilutive financing program.

  • Reverse Stock Split Authorized

    Shareholders authorized the Board to implement a reverse stock split with a ratio between 1-for-5 and 1-for-100, primarily to maintain the company's Nasdaq listing.

  • Directors Elected

    Khurram P. Sheikh and George Mathai were elected as Class III directors to serve until the 2028 annual meeting.


Analysis · CXAI · Technology

This 8-K reports the results of CXApp Inc.'s Annual Meeting, where shareholders approved two critical proposals. First, they authorized the company to issue shares in private placements exceeding 20% of outstanding common stock, which enables the previously announced $40 million highly dilutive equity financing program. This is a significant step for a company with a $15.5 million market cap, indicating substantial future dilution. Second, shareholders authorized the Board to implement a reverse stock split (1-for-5 to 1-for-100) to address the Nasdaq listing deficiency, a necessary measure given the current stock price of $0.22. These approvals are crucial for the company's immediate financial stability and continued listing, but come with a high cost of dilution for existing shareholders.

At the time of this filing, CXAI was trading at $0.22 on NASDAQ in the Technology sector, with a market capitalization of approximately $15.5M. The 52-week trading range was $0.13 to $1.15. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CXAI - Latest Insights

CXAI
Jul 06, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1678
Real-time Price: $0.1635 info
Change: -$0.0043 (-3%) info
Market Cap: $11.214M info
CXAI
Jun 03, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.1876
Real-time Price: $0.1635 info
Change: -$0.0241 (-13%) info
Market Cap: $11.214M info
CXAI
Jun 03, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.175969
Real-time Price: $0.1635 info
Change: -$0.012469 (-7%) info
Market Cap: $11.214M info
CXAI
Jun 03, 2026, 4:30 PM EDT
Source: ACCESS Newswire
Importance Score:
9
Price at Filing: $0.1612
Real-time Price: $0.1635 info
Change: +$0.0023 (+1%) info
Market Cap: $11.214M info
CXAI
May 28, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.177
Real-time Price: $0.1635 info
Change: -$0.0135 (-8%) info
Market Cap: $11.214M info